746 studies found for:    Alexander Disease
Show Display Options
Rank Status Study
21 Recruiting Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities
Condition: Peripheral Artery Disease
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Rivaroxaban-Placebo
22 Recruiting Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: PF-02545920;   Other: Placebo
23 Recruiting Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
Condition: Huntington's Disease
Intervention: Drug: 20 mg BID of PF-02545920
24 Recruiting Adjuvant Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy
Condition: Uveal Melanoma
Intervention: Drug: crizotinib
25 Recruiting Catheter Placement for Hepatic Hydrothorax
Condition: Pleural Effusion
Intervention: Device: Indwelling tunneled pleural catheter (ITPC)
26 Recruiting Levetiracetam for Alzheimer's Disease-Associated Epileptiform Activity
Condition: Early-onset Alzheimer's Disease
Intervention: Drug: levetiracetam
27 Recruiting Group Versus Internet-based Cognitive Behavior Therapy for Procrastination
Condition: Procrastination
Interventions: Behavioral: Cognitive behavior group therapy;   Behavioral: Internet-based cognitive behavior therapy
28 Terminated Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease
Condition: Coronary Artery Disease
Intervention: Drug: PB127 for Injectable Suspension
29 Completed Behavioral Activation for Posttraumatic Stress Disorder (PTSD)/ Depression Treatment in Operations Iraqi Freedom and Enduring Freedom (OIF/OEF) Veterans
Conditions: Posttraumatic Stress Disorder;   Depression
Interventions: Behavioral: Behavioral Activation treatment;   Other: Usual VA Treatment for PTSD
30 Terminated
Has Results
SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study
Condition: Major Depressive Disorder
Intervention: Drug: SPD489 (Lisdexamfetamine dimesylate) + Antidepressant
31 Completed
Has Results
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate );   Drug: Antidepressant + Placebo
32 Completed
Has Results
Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis
Condition: Kidney Failure, Chronic
Interventions: Drug: Placebo;   Drug: Genz-644470;   Drug: Sevelamer carbonate
33 Active, not recruiting Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil
Condition: Alzheimer's Disease
Interventions: Drug: PF-05212377 (SAM-760);   Other: Placebo
34 Unknown  A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage
Condition: Small Cell Lung Cancer
Intervention: Drug: Carboplatin plus Irinotecan vs Carboplatin plus Etoposide
35 Completed Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety
Conditions: Major Depressive Disorder;   Anxiety
Intervention: Drug: BCI-540
36 Unknown  Psychological Effects of Tai Chi Training
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Behavioral: Tai Chi training
37 Recruiting A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder
Condition: Autism Spectrum Disorder
Interventions: Drug: IGF-1;   Drug: Placebo/saline
38 Completed Dose Finding Study of PB127 Ultrasound Contrast Agent in Healthy Volunteers and Patients With Coronary Artery Disease
Conditions: Healthy;   Coronary Artery Disease
Intervention: Drug: PB127 for Injectable Suspension
39 Terminated
Has Results
One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome
Condition: Bipolar Disorder
Intervention: Drug: Ziprasidone HCL (oral)
40 Not yet recruiting PACT for Individuals With Serious Mental Illness
Condition: Schizophrenia and Disorders With Psychotic Feature
Intervention: Other: Patient Aligned Care Team (PACT)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years